Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Digestive Diseases and Sciences

• Publication date

  2015-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10620-015-3607-yPMID 25784074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report

  2015cited by this paper
• Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double‐blind, placebo‐controlled trial

  2014cited by this paper
• Associations between IL‐1RA polymorphisms and small intestinal bacterial overgrowth among patients with irritable bowel syndrome from India

  2014cited by this paper
• Alterations of the gut microbiome and metabolome in alcoholic liver disease.

  2014cited by this paper
• Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes

  2013cited by this paper
• Interactions between Bifidobacterium and Bacteroides Species in Cofermentations Are Affected by Carbon Sources, Including Exopolysaccharides Produced by Bifidobacteria

  2013cited by this paper
• Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome

  2013influential reference
• Role of commensal gut bacteria in inflammatory bowel diseases

  2012cited by this paper
• The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?

  2012influential reference
• Distinct microbial populations exist in the mucosa‐associated microbiota of sub‐groups of irritable bowel syndrome

  2012cited by this paper
• The microbiota link to irritable bowel syndrome

  2012cited by this paper
• Microbial community and metabolomic comparison of irritable bowel syndrome faeces

  2011influential reference
• Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome.

  2011cited by this paper
• Enterotypes of the human gut microbiome

  2011cited by this paper
• Abnormal expansion of segmented filamentous bacteria in the gut: a role in pathogenesis of chronic inflammatory intestinal diseases?

  2011cited by this paper
• Rifaximin therapy for patients with irritable bowel syndrome without constipation.

  2011cited by this paper
• Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

  2010cited by this paper
• VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Crossover Study

  2010cited by this paper
• From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome

  2010cited by this paper
• Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

  2010cited by this paper
• Detection of Human Intestinal Catalase-Negative, Gram-Positive Cocci by rRNA-Targeted Reverse Transcription-PCR

  2010influential reference
• Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives.

  2010influential reference
• Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

  2009cited by this paper
• Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

  2009influential reference
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients.

  2009cited by this paper
• Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm

  2009cited by this paper
• Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

  2009cited by this paper
• Review article: probiotics and prebiotics in irritable bowel syndrome

  2008cited by this paper
• Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

  2008cited by this paper
• Gastrointestinal Microbiota in Irritable Bowel Syndrome: Their Role in Its Pathogenesis and Treatment

  2008cited by this paper
• Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov

  2008cited by this paper
• The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.

  2007cited by this paper
• FUNCTIONAL BOWEL DISORDERS

  2007cited by this paper
• New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

  2007cited by this paper
• Immune activation in patients with irritable bowel syndrome.

  2007cited by this paper
• [Use of Rome III criteria for diagnosing irritable bowel syndrome].

  2006cited by this paper
• Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease

  2006influential reference
• CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT

  2005cited by this paper
• Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells.

  2005influential reference
• Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

  2005cited by this paper
• Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

  2005influential reference
• Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut

  2004influential reference
• Characterization of Bacterial Communities in Feces from Healthy Elderly Volunteers and Hospitalized Elderly Patients by Using Real-Time PCR and Effects of Antibiotic Treatment on the Fecal Microbiota

  2004cited by this paper
• Use of Real-Time PCR with Multiple Targets To Identify Pseudomonas aeruginosa and Other Nonfermenting Gram-Negative Bacilli from Patients with Cystic Fibrosis

  2003cited by this paper
• Gram Type-Specific Broad-Range PCR Amplification for Rapid Detection of 62 Pathogenic Bacteria

  1999cited by this paper
• Distribution of Bifidobacterial Species in Human Intestinal Microflora Examined with 16S rRNA-Gene-Targeted Species-Specific Primers

  1999influential reference
• Gram Type-Specific Broad-Range PCR Amplification for Rapid Detection of 62 Pathogenic Bacteria

  1999cited by this paper
• Abnormal colonic fermentation in irritable bowel syndrome.

  1998cited by this paper
• Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.

  1996cited by this paper
• The fecal microbial population in the irritable bowel syndrome.

  1982cited by this paper
• Journal of Neurogastroenterology and Motility Review Irritable Bowel Syndrome, Gut Microbiota and

  year unknowncited by this paper

• Segmented filamentous bacteria are worldwide human gut commensals.

  2026cites this paper
• Altered molecular signature of the intestinal microbiota in irritable bowel syndrome patients versus healthy controls: An updated systematic review.

  2025cites this paper
• Meta-analysis of faecal microbiome studies followed by machine learning to identify intestinal disease-specific taxonomic signatures.

  2025cites this paper
• Gut Virome: What's the Role in Irritable Bowel Syndrome?

  2025cites this paper
• Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies

  2025cites this paper
• Introducing blueberry powder as one of the first complementary foods changes the gut microbiota composition and diversity in U.S. human milk-fed infants: a double-blind, randomized controlled trial

  2025cites this paper
• The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-Analysis

  2025cites this paper
• Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions

  2025cites this paper
• Factors Contributing to the Efficacy of Fecal Microbiota Transplantation for Diarrhea-Dominant Functional Bowel Disorders

  2025cites this paper
• Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay

  2025cites this paper
• Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome

  2025cites this paper
• Gut Microecological Prescription: A Novel Approach to Regulating Intestinal Micro-Ecological Balance

  2025cites this paper
• Prevalence of ESBL resistance genes and fecal carriage of multidrug-resistant Pseudomonas aeruginosa isolates from patients with chronic kidney disease at the Laquintinie Hospital in Douala, Littoral Region, Cameroon.

  2025cites this paper
• Mechanism of Epigallocatechin-3-gallate in the Prevention and Treatment of Irritable Bowel Syndrome: A Network Pharmacology and Gene Expression Omnibus Chip Data-Based Study

  2025cites this paper
• Gut microbiota and irritable bowel syndrome: status and prospect

  2024cites this paper
• Common questions and rationale answers about the intestinal bacterial overgrowth syndrome (SIBO)

  2024cites this paper
• Effects of a green seaweed from the Atlantic coast (Ulva lactuca) on gut microbiota, using an in vitro colon model

  2024cites this paper
• Consumption of resistant potato starch produces changes in gut microbiota that correlate with improvements in abnormal bowel symptoms: a secondary analysis of a clinical trial

  2024cites this paper
• Biscuits for the gut: A symphony of FODMAPs and dietary fibre in gut microbiome for irritable bowel syndrome (IBS) management

  2024cites this paper
• Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research

  2024cites this paper
• Effects of CRAMP on the gut-brain axis in experimental sepsis.

  2024cites this paper
• Crisis in the gut: navigating gastrointestinal challenges in Gulf War Illness with bioengineering

  2024cites this paper
• Treating chronic stress and chronic pain by manipulating gut microbiota with diet: can we kill two birds with one stone?

  2024cites this paper
• Preguntas Comunes Y Respuestas Razonadas Sobre El Síndrome Del Sobrecrecimiento Bacteriano Intestinal (SIBO)

  2024cites this paper
• From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?

  2024cites this paper
• Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability.

  2024cites this paper
• Effect of web-based personalized nutrition management on gut microbiota in Korean patients with irritable bowel syndrome aged between 20 and 30 years

  2024cites this paper
• Cryptosporidium and irritable bowel syndrome

  2024cites this paper
• Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota.

  2024cites this paper
• Relationship among Chinese herb polysaccharide (CHP), gut microbiota, and chronic diarrhea and impact of CHP on chronic diarrhea

  2023cites this paper
• Structure and Metabolic Activity of the Gut Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Combined with Functional Dyspepsia

  2023cites this paper
• Gut microbiota and irritable bowel syndrome

  2023cites this paper
• Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS

  2023cites this paper
• Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology

  2023cites this paper
• Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications

  2023influential citation
• Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn’s disease

  2022cites this paper
• Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.

  2022cites this paper
• Bifidobacteria Was Decreased in Adult Patients With Irritable Bowel Syndrome Based on PCR and Bacterial Culture: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Progress in application of probiotics, prebiotics, and synbiotics in irritable bowel syndrome

  2022cites this paper
• Multi-similarity fusion-based label propagation for predicting microbes potentially associated with diseases

  2022cites this paper
• Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?

  2022cites this paper
• Probiotics and Phytochemicals: Role on Gut Microbiota and Efficacy on Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation

  2022cites this paper
• Gluten: do only celiac patients benefit from its removal from the diet?

  2022cites this paper
• Emerging Role of Gut Microbiota in Functional Gastrointestinal Disorders

  2022cites this paper
• Characteristics of gut microbiota and fecal metabolomes in patients with celiac disease in Northwest China

  2022cites this paper
• Alteration of the faecal microbiota composition in patients with constipation: evidence of American Gut Project.

  2022cites this paper
• Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders

  2022cites this paper
• Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome

  2022cites this paper
• Role of gut microbiota-derived signals in the regulation of gastrointestinal motility

  2022cites this paper
• Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome

  2021cites this paper
• Effects of the antibiotic rifaximin on cortical functional connectivity are mediated through insular cortex

  2021cites this paper
• Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease

  2021cites this paper
• Effect of xylanase and xylo-oligosaccharide supplementation on growth performance and faecal bacterial community composition in growing pigs

  2021cites this paper
• Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease

  2021cites this paper
• Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

  2021influential citation
• Carriage of Cdt-B Encoding Campylobacter spp., Salmonellaenterica, and Yersinia entercolitica in Patients with Gastroenteritis, Irritable Bowel Syndrome, and Controls

  2021cites this paper
• Mechanism of Lactobacillus rhamnosus in treatment of irritable bowel syndrome

  2021cites this paper
• Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial

  2021cites this paper
• Treating the Metabolic Syndrome by Fecal Transplantation—Current Status

  2021cites this paper
• Early-Life Intervention Using Exogenous Fecal Microbiota Alleviates Gut Injury and Reduce Inflammation Caused by Weaning Stress in Piglets

  2021cites this paper
• Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome

  2021cites this paper
• Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.

  2021cites this paper
• Integrated Bacterial and Fungal Diversity Analysis Reveals the Gut Microbial Alterations in Diarrheic Giraffes

  2021cites this paper
• Gut microbiota profiles and the role of anti‐CdtB and anti‐vinculin antibodies in patients with functional gastrointestinal disorders (FGID)

  2021cites this paper
• Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review

  2021cites this paper
• Microbiota and the irritable bowel syndrome.

  2021cites this paper
• The Intestinal Biofilm of Pseudomonas aeruginosa and Staphylococcus aureus Is Inhibited by Antimicrobial Peptides HBD-2 and HBD-3

  2021cites this paper
• Role of microRNAs in Disorders of Gut–Brain Interactions: Clinical Insights and Therapeutic Alternatives

  2021cites this paper
• The Role of Segmented Filamentous Bacteria in Immune Barrier Maturation of the Small Intestine at Weaning

  2021cites this paper
• Contribution of Gut Microbiota to Immune Tolerance in Infants

  2021cites this paper
• In uence of Low FODMAP and Gluten-Free Diets on Gut Microbiota Alternations and Symptom Severity in Iranian Patients With Irritable Bowel Syndrome; A Clinical Trial Study

  2021cites this paper
• Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.

  2020cites this paper
• Fecal Microbiota Transplantation in Intestinal Disorders: A Primer for Physicians

  2020cites this paper
• Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome

  2020cites this paper
• Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track

  2020cites this paper
• The impact of a low FODMAP diet on the reduction of irritable bowel syndrome symptoms and changes in intestinal microbiota in patients – a review of current research

  2020cites this paper
• Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders

  2020cites this paper
• Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial.

  2020cites this paper
• Effect of Gluten-Free Diet on Gut Microbiota Composition in Patients with Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity

  2020influential citation
• Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients

  2020cites this paper
• Comparison of gut microbiota profile in celiac disease, non-celiac gluten sensitivity and irritable bowel syndrome: A systematic review.

  2020influential citation
• Soluble arabinoxylans extracted from soft and hard wheat show a differential prebiotic effect in vitro and in vivo

  2020cites this paper
• Potential Determinants of Gastrointestinal Dysfunction in Autism Spectrum Disorders

  2020cites this paper
• Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise—Searching for Gap Fillers in the Oxidative Stress Way of Thinking

  2020cites this paper
• Carriage of CdtB Encoding Campylobacter spp., Salmonella enterica, and Yersinia entercolitica in Patients with Gastroenteritis and Irritable Bowel Syndrome

  2020cites this paper
• Aerobic Exercise Training with Brisk Walking Increases Intestinal Bacteroides in Healthy Elderly Women

  2019cites this paper
• The Rome IV: Irritable bowel syndrome - A functional disorder.

  2019cites this paper
• Second Asian Consensus on Irritable Bowel Syndrome

  2019cites this paper
• The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

  2019cites this paper
• Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota

  2019cites this paper
• Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.

  2019cites this paper
• β-Xylosidase and β-mannosidase in combination improved growth performance and altered microbial profiles in weanling pigs fed a corn-soybean meal-based diet

  2019influential citation
• Structural characterization of water-soluble polysaccharide from Arctium lappa and its effects on colitis mice.

  2019cites this paper
• Potential Determinants of Gastrointestinal Dysfunction in Autism Spectrum Disorders

  2019cites this paper
• Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial

  2019cites this paper
• Distribution and Strain Diversity of Immunoregulating Segmented Filamentous Bacteria in Human Intestinal Lavage Samples

  2019cites this paper
• Targeting the gut microbiota for the treatment of irritable bowel syndrome

  2019cites this paper
• Microbiome, Immunomodulation, and the Neuronal System

  2018cites this paper
• Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome

  2018cites this paper
• First Insights into the Gut Microbiota of Mexican Patients with Celiac Disease and Non-Celiac Gluten Sensitivity

  2018cites this paper